Pozen Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment - Drugs.com MedNews

Links shared publicly online about this topic.

  • 418
    total visits

Pozen Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment - Drugs.com MedNews

drugs.com —

Mar 23, 2011 - POZEN Inc. (NASDAQ POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered

View full resource at drugs.com

Tags: Migraine, Headache, Vascular Headache, Drug, Pharma, Johnson & Johnson, Medical

  • Share

Most Recently Shared on March 24, 2011 at 2:14 am By:

Migraine_Wisdom Migraine OW

Pozen Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment:... http://bit.ly/hFzlGq

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

Drugs and Devices OW Drugs and Devices OW

Advertisement